|
| (AFX UK Focus) 2009-09-06 19:09 Amgen shares cheap, could get FDA boost-Barron's |
6 Sep 09, 18:11 |
|
| NEW YORK, Sept 6 (Reuters) - Amgen Inc's relatively inexpensive shares are likely to rise once the U.S. Food and Drug Administration decides next month whether to approve the biotech company's bone-loss antibody, denosumab, according to Barron's. Amgen shares could fall to their 2008 low, around $45, if the FDA rejects or slows the approval process for the drug, it said in its Sept. 7 edition ... |
| more |
|
